Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

$244.3B

Market Cap • 11/18/2024

1970

(54 years)
Founded

1949

(75 years ago)
IPO

NYSE

Listing Exchange
Flag of US

Rahway

Headquarters • New Jersey

S&P500 Participant

Index Composite • 2024